171 related articles for article (PubMed ID: 36464877)
1. Post-COVID-19 Gastro-Intestinal Disturbances.
Scarpellini E; Tack J
Rev Recent Clin Trials; 2023; 18(1):34-40. PubMed ID: 36464877
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
3. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic.
Gubatan J; Zikos T; Spear Bishop E; Wu J; Gottfried A; Becker L; Habtezion A; Neshatian L
Neurogastroenterol Motil; 2022 Apr; 34(4):e14243. PubMed ID: 34378840
[TBL] [Abstract][Full Text] [Related]
5. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
Austhof E; Bell ML; Riddle MS; Catalfamo C; McFadden C; Cooper K; Scallan Walter E; Jacobs E; Pogreba-Brown K
Epidemiol Infect; 2022 Jul; 150():e136. PubMed ID: 35801302
[TBL] [Abstract][Full Text] [Related]
6. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
Schurman JV; Karazsia BT; Friesen CA
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
[TBL] [Abstract][Full Text] [Related]
7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
8. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
Estremera-Arevalo F; Barcelo M; Serrano B; Rey E
World J Gastroenterol; 2019 Feb; 25(7):837-847. PubMed ID: 30809083
[TBL] [Abstract][Full Text] [Related]
9. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.
Yao X; Yang YS; Cui LH; Sun G; Peng LH; Wang WF; Hyder Q; Zhang XL
J Gastroenterol Hepatol; 2016 Sep; 31(9):1584-93. PubMed ID: 26875585
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
[TBL] [Abstract][Full Text] [Related]
11. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
Talley NJ; Holtmann G; Walker MM
J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review.
Paramythiotis D; Karlafti E; Didagelos M; Fafouti M; Veroplidou K; Protopapas AA; Kaiafa G; Netta S; Michalopoulos A; Savopoulos C
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004010
[TBL] [Abstract][Full Text] [Related]
14. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
Staudacher HM; Whelan K
Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome.
Ghoshal UC; Ghoshal U
Curr Opin Infect Dis; 2023 Oct; 36(5):366-370. PubMed ID: 37606895
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.
Hammer J; Eslick GD; Howell SC; Altiparmak E; Talley NJ
Gut; 2004 May; 53(5):666-72. PubMed ID: 15082584
[TBL] [Abstract][Full Text] [Related]
17. [Impact of the COVID pandemic on the anxiety of patients with functional gastrointestinal symptoms].
Goebel-Stengel M; Lohmiller J; Schäffeler N; Zipfel S; Stengel A
Z Gastroenterol; 2022 Apr; 60(4):575-585. PubMed ID: 35176808
[TBL] [Abstract][Full Text] [Related]
18. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey.
Nakov R; Dimitrova-Yurukova D; Snegarova V; Nakov V; Fox M; Heinrich H
Neurogastroenterol Motil; 2022 Feb; 34(2):e14197. PubMed ID: 34145679
[TBL] [Abstract][Full Text] [Related]
20. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
